We are live on
!
Find out more
QT
Quantamental Technologies Portfolio holdings
AUM
$106M
1-Year Est. Return
22.9%
This Fund
S&P 500
This Quarter
Est. Return
+4.46%
1 Year Est. Return
+22.9%
3 Year Est. Return
+24.21%
5 Year Est. Return
+49.29%
10 Year Est. Return
–
AUM
$271M
AUM Growth
+$52.4M
(+24%)
Cap. Flow
+$47.7M
Cap. Flow
% of AUM
17.59%
Top 10 Holdings %
Top 10 Hldgs %
6.2%
Holding
2,003
New
530
Increased
458
Reduced
406
Closed
533
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$2.5M |
| 2 |
Lockheed Martin
LMT
|
+$1.94M |
| 3 |
Nike
NKE
|
+$1.74M |
| 4 |
Extra Space Storage
EXR
|
+$1.46M |
| 5 |
L3Harris
LHX
|
+$1.32M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$1.27M |
| 2 |
Walmart Inc
WMT
|
+$1.08M |
| 3 |
Herbalife
HLF
|
+$1.01M |
| 4 |
Palo Alto Networks
PANW
|
+$984K |
| 5 |
SNV
Synovus
SNV
|
+$913K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.59% |
| 2 | Technology | 15.24% |
| 3 | Industrials | 13.44% |
| 4 | Consumer Discretionary | 12.69% |
| 5 | Healthcare | 11.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CCXI
926
DELISTED
ChemoCentryx, Inc.
CCXI
| $46K | 0.02% |
+4,906
| New | +$56.8K |
|
927
Editas Medicine
EDIT
$402M
| $45K | 0.02% |
+1,811
| New | +$43.2K |
|
928
New York Times
NYT
$12.2B
| $45K | 0.02% |
1,375
-1,808
| -57% | -$60.2K |
|
929
Titan Machinery
TITN
$458M
| $45K | 0.02% |
+2,209
| New | +$37.1K |
|
930
Amneal Pharmaceuticals
AMRX
$5.99B
| $44K | 0.02% |
6,123
-577
| -9% | -$5.9K |
|
931
Codexis
CDXS
$161M
| $44K | 0.02% |
+2,393
| New | +$46.1K |
|
|
DHIL
932
DELISTED
Diamond Hill
DHIL
| $44K | 0.02% |
307
+204
| +198% | +$29.1K |
|
933
McGrath RentCorp
MGRC
$2.95B
| $44K | 0.02% |
715
-389
| -35% | -$23.3K |
|
934
Douglas Dynamics
PLOW
$1.04B
| $44K | 0.02% |
1,105
-200
| -15% | -$7.61K |
|
935
Team
TISI
$80.6M
| $44K | 0.02% |
+285
| New | +$46K |
|
936
Wave Life Sciences
WVE
$1.13B
| $44K | 0.02% |
+1,691
| New | +$47.4K |
|
937
BioCryst Pharmaceuticals
BCRX
$2.48B
| $43K | 0.02% |
+11,389
| New | +$68.5K |
|
938
NRC Health Common Stock
NRC
$503M
| $43K | 0.02% |
743
+413
| +125% | +$19.1K |
|
|
TCDA
939
DELISTED
Tricida, Inc. Common Stock
TCDA
| $43K | 0.02% |
1,100
+100
| +10% | +$3.52K |
|
|
PLAN
940
DELISTED
Anaplan, Inc.
PLAN
| $43K | 0.02% |
+850
| New | +$35.1K |
|
941
Amphastar Pharmaceuticals
AMPH
$888M
| $42K | 0.02% |
1,987
-925
| -32% | -$19.3K |
|
942
Huron Consulting
HURN
$1.97B
| $42K | 0.02% |
+831
| New | +$40.7K |
|
943
Itaú Unibanco
ITUB
$91.6B
| $42K | 0.02% |
+6,162
| New | +$38.8K |
|
944
St. Joe Company
JOE
$3.57B
| $42K | 0.02% |
2,438
+800
| +49% | +$13.4K |
|
945
Methode Electronics
MEI
$525M
| $42K | 0.02% |
+1,487
| New | +$41.6K |
|
946
Prothena Corp
PRTA
$448M
| $42K | 0.02% |
4,013
-116
| -3% | -$1.19K |
|
947
Qorvo
QRVO
$8.09B
| $42K | 0.02% |
+629
| New | +$43.7K |
|
|
RC
948
Ready Capital
RC
$261M
| $42K | 0.02% |
2,802
+602
| +27% | +$8.92K |
|
949
Solid Biosciences
SLDB
$785M
| $42K | 0.02% |
+484
| New | +$52.8K |
|
950
Tidewater
TDW
$3.71B
| $42K | 0.02% |
1,800
+1,100
| +157% | +$25.3K |
|
Similar funds
KC
SA
GG
FHCM
AEPLI
ASA
MAP
DCS
Quantamental Technologies's Q2 2019 Portfolio in Review
As of Q2 2019, Quantamental Technologies held 2,003 positions worth $271M, up 24% from $219M the previous quarter. Its ten largest holdings account for 6.2% of the portfolio.
Quantamental Technologies deployed $47.7M of net new capital in Q2 2019, opening 530 new positions and adding to 458 existing holdings. Its largest new stake was Morgan Stanley: 56,144 shares worth $2.46M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Medtronic, an estimated $1.27M trimmed.
- Quantamental Technologies's largest Q2 2019 buy was Morgan Stanley: 56,144 shares worth $2.46M.
- Quantamental Technologies added most to L3Harris in Q2 2019, an estimated $1.32M increase.
- Quantamental Technologies's biggest Q2 2019 reduction was Medtronic, cutting an estimated $1.27M.
- Quantamental Technologies fully exited Walmart Inc in Q2 2019, selling an estimated $1.08M.
- Quantamental Technologies's ten largest holdings make up 6.2% of its $271M portfolio in Q2 2019.
- Quantamental Technologies opened 530 new positions and closed 533 in Q2 2019.
- Quantamental Technologies's portfolio value rose 24% quarter-over-quarter to $271M.
Based on Quantamental Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.